Objective:To investigate the regulatory effect of the macrophage-derived C-X-C motif chemokine ligand 8 (CXCL8) on the STAT1-IFN-Ⅰ signaling axis during islet inflammation in type 1 diabetes mellitus (T1DM).Methods:T1DM immune-related differentially expressed genes were identified using human islet transcriptome datasets (GSE102371, GSE108413) from the GEO database and PANCDB single-cell sequencing datasets. Peripheral blood samples were collected from 57 children with T1DM and 37 healthy control children at the Children's Hospital affiliated to Nanjing Medical University from October 2023 to January 2026. Islet tissue was also collected from one healthy individual. Quantitative PCR was used to detect mRNA expression of
CXCL8 and related genes in human islets, THP-1 cells, and peripheral blood mononuclear cell (PBMC). ELISA was used to measure serum CXCL8 levels, and Western blotting was used to detect total STAT1 protein expression and phosphorylation at the Y701 site in THP-1 cells. Lentivirus-mediated overexpression of
CXCL8 in THP-1 cells combined with transcriptome sequencing was used to analyze its function. Linear regression models were used to evaluate the associations of serum CXCL8 with fasting plasma glucose (FPG), glycated hemoglobin (HbA
1c), C-peptide (CP), and insulin, adjusting for age, sex, and diabetes duration. Receiver operating characteristic (ROC) curves were constructed to assess diagnostic value.
Results:A total of 57 T1DM children had a mean age of (8.7±3.4) years, and included 27 males (47.4%) and 30 females (52.6%). The 37 healthy controls had a mean age of (8.1±2.9) years, and included 20 males (54.1%) and 17 females (45.9%). Single-cell sequencing data showed that
CXCL8 was mainly expressed in islet macrophages, with higher expression in patients with T1DM than in healthy controls (
P<0.01).
CXCL8 mRNA expression in PBMC of T1DM children was higher than that of healthy controls (10.56±2.01
vs. 1.00±0.23,
P<0.001), and serum CXCL8 levels were also elevated (
P<0.001).
In vitro experiments demonstrated that
CXCL8 overexpression enhanced IFN-α-induced phosphorylation at STAT1 Y701 and total STAT1 protein expression, and upregulated the expression of interferon-stimulated genes
IFIT3,
IFIT2,
IFI6,
MX1,
IFI44L,
OASL,
EPSTI1, and
ISG15 (all
P<0.05); the expression of these genes was also higher in PBMC of T1DM children than in controls (all
P<0.05). Serum CXCL8 was positively correlated with FPG (
B=8.45, 95%CI 3.78-13.12,
P<0.001) and HbA
1c (
B=7.11, 95%CI 4.97-9.25,
P<0.001), and negatively correlated with CP (
B=-0.17, 95%CI -0.32 to -0.01,
P=0.044) and insulin (
B=-7.32, 95%CI -13.50 to -0.86,
P=0.031). The area under the ROC curve of serum CXCL8 for diagnosing T1DM was 0.925 (95%CI 0.861-0.989), with a sensitivity of 100% and specificity of 83.3%.
Conclusions:CXCL8 may contribute to islet inflammation and T1DM progression by activating the macrophage STAT1-IFN-Ⅰ signaling pathway and has potential as a biomarker for T1DM.